The Effects of Cigarette Addiction on Lower Extremity Movement Speed and Coordination

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-29

Study Completion Date

2026-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study will aim to investigate the effects of cigarette addiction on lower extremity motor coordination and movement speed in young adults. The study will include healthy participants aged 18-25 years, divided into smokers and non-smokers. Motor coordination will be assessed using the Lower Extremity Motor Coordination Test (LEMOCOT), and speed will be evaluated with a 30-meter sprint test. Nicotine dependence will be evaluated in smokers using the Fagerström Test. The findings will provide insight into the possible functional impacts of nicotine addiction on motor performance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Smoking Addiction on Lower Limb Speed and Coordination

NCT07061522

Smoking Cessation

RECRUITING

Impact of Smoking on Physical Activity Level in Young Adults

NCT07043920

Smoking Behaviors Physical Inactivity

RECRUITING

Effects of Exercise and Nicotine on Cognition in Smokers

NCT03091699

Smoking Cessation

COMPLETED PHASE3

Smokers' Health Project: Self-Determination and Maintaining Tobacco Abstinence

NCT00178685

Tobacco Use Disorder

COMPLETED PHASE4

Effectiveness of Spirometry as a Motivational Tool to Quit Smoking

NCT01821885

Smoking Cessation COPD

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will be conducted as a non-randomized controlled observational trial at the Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. A total of 24 healthy young adults (12 smokers, 12 non-smokers) will participate. The inclusion criteria will require participants to be aged 18-25, cooperative, literate, and able to walk independently. Participants will be categorized as smokers based on WHO and DSM-IV-TR criteria. The primary assessments will include LEMOCOT and 30-meter sprint test. Nicotine addiction will be measured using the Fagerström Test for Nicotine Dependence (FTND), and anthropometric data including BMI and bimalleolar diameter will also be recorded. Data will be analyzed to determine any statistical differences or correlations between smoking status and motor performance outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Smokers

Individuals who will meet WHO and DSM-IV-TR criteria for cigarette dependence.

Behavioral and Functional Performance Assessment Battery

Intervention Type DIAGNOSTIC_TEST

This study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological intervention will be applied.

Non-Smokers

Individuals who will report no smoking behavior in the past year.

Behavioral and Functional Performance Assessment Battery

Intervention Type DIAGNOSTIC_TEST

This study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological intervention will be applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral and Functional Performance Assessment Battery

This study will include only observational functional assessments. No active intervention will be performed.This observational protocol will involve standardized assessments of lower extremity coordination (LEMOCOT), movement speed (30-meter sprint), and smoking-related behavioral patterns (Fagerström Test for Nicotine Dependence). These tools will be used to evaluate the potential impact of cigarette addiction on physical performance in young adults. No therapeutic or pharmacological intervention will be applied.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 25 years
* Able to walk independently
* Literate and cooperative
* Willing to participate voluntarily
* BMI between 18.5 and 29.9 kg/m²

Additional inclusion for smokers:

* Daily smoking for at least one year based on WHO and DSM-IV-TR definitions

Exclusion Criteria

* Orthopedic, neurologic, or neuromuscular disorders affecting gait
* Chronic cardiopulmonary disease
* Cognitive impairments
* Obesity (BMI ≥ 30 kg/m²)

Additional exclusion for smokers:

* History of acute cardiovascular events
* Chronic heart failure or lung diseases

Minimum Eligible Age

18 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No